Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Philip Georgevich

Vascular Surgery Mc Kees Rocks, PA Medical Doctor

NPI 1114980570 CMS profile 277152

27 Heckel Rd, Suite 206, Mc Kees Rocks, PA 15136

Open in the dashboard

General payments

$3,331

85 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Philip Georgevich of Mc Kees Rocks, PA is reported in the CMS Open Payments database as having received $3,331 across 85 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 40th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $1,143 12
2022 General $373 15
2021 General $301 10
2020 General $487 13
2019 General $1,026 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philip Georgevich
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Philip Georgevich were reported at $0. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Philip Georgevich Vascular Surgery median Middle half National median
2019 $1,026 $796 $226–$2,363 $163
2020 $487 $348 $118–$1,110 $114
2021 $301 $471 $158–$1,421 $132
2022 $373 $725 $222–$2,183 $149
2023 $1,143 $836 $257–$2,440 $160
2024 $0 $909 $252–$2,619 $164
2025 $0 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Medtronic, Inc. $1,155 22 payments
  2. Organogenesis Inc. $318 3 payments
  3. Smith+Nephew, Inc. $297 14 payments
  4. Davol Inc. $294 12 payments
  5. W. L. Gore & Associates, Inc. $198 3 payments
  6. Misonix Inc $186 7 payments
  7. Tactile Systems Technology Inc $179 1 payment
  8. Medtronic Vascular, Inc. $140 13 payments
  9. Kerecis Limited $138 2 payments
  10. Janssen Pharmaceuticals, Inc $118 1 payment
  11. Other $308 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $2,380 78 payments
  2. Travel and Lodging $950 7 payments
Products named General payments · program years 2019–2023
  1. VENASEAL $961 7 payments
  2. Flexitouch Plus $179 1 payment
  3. entre $179 1 payment
  4. VIABAHN Endoprosthesis with Heparin Bioactive Surface $161 2 payments
  5. Santyl $161 10 payments
  6. ENDURANT IIS $128 12 payments
  7. Endurant $126 12 payments
  8. Puraply $122 1 payment
  9. XARELTO $118 1 payment
  10. Kerecis Omega3 Wound $114 1 payment
  11. Other $1,081 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

35

Median for General Surgery: 59

Drug cost

$709

Median for General Surgery: $393

Branded share of claims

100%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lactated Ringers Ringer's Solution,lactated Brand 35 $709

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record